Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
P.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.2 (Zeta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.499NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.212NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.61NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.86NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.41.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GS.4.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JF.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JG.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBBNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.62NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FR.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FR.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FU.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBL.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.24.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.9.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FE.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FR.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.4.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.5.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used